{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:04:24Z","timestamp":1785942264105,"version":"3.56.0"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Neuropharmacology"],"published-print":{"date-parts":[[1990,10]]},"DOI":"10.1097\/00002826-199010000-00007","type":"journal-article","created":{"date-parts":[[2006,10,26]],"date-time":"2006-10-26T05:04:35Z","timestamp":1161839075000},"page":"459-460","source":"Crossref","is-referenced-by-count":4,"title":["Methylphenidate for Reversal of Drug-Induced Coma"],"prefix":"10.1097","volume":"13","author":[{"given":"Frederick J.","family":"Lichtigfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Gillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002826-199010000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:26:14Z","timestamp":1785939974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-199010000-00007"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[1990,10]]},"references-count":0,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1097\/00002826-199010000-00007","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[1990,10]]}}}